App is temporarily unavailable
CVIT2023
Description
Welcome to the official mobile phone app for The 31st Annual Meeting of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT2023) in Fukuoka, JAPAN August 4 - August 6, 2023
Features include:
- Search abstract by author's name, affiliation, keyword etc.
- Create your itinerary with bookmarked sessions and your personal event
- View the ongoing sessions onsite
- View the venue map
Hide
Show More...
Features include:
- Search abstract by author's name, affiliation, keyword etc.
- Create your itinerary with bookmarked sessions and your personal event
- View the ongoing sessions onsite
- View the venue map
Screenshots
CVIT2023 FAQ
-
Is CVIT2023 free?
Yes, CVIT2023 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is CVIT2023 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does CVIT2023 cost?
CVIT2023 is free.
-
What is CVIT2023 revenue?
To get estimated revenue of CVIT2023 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Chile yet.
Ratings History
CVIT2023 Reviews
CVIT2023 Installs
Last 30 days
CVIT2023 Revenue
Last 30 daysCVIT2023 Revenue and Downloads
Gain valuable insights into CVIT2023 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Languages
- English, Japanese
- Recent release
- 1.0.0 (1 year ago )
- Released on
- Jul 26, 2023 (1 year ago )
- Also available in
- Hong Kong SAR China , South Africa , United States , Türkiye , Russia , Romania , Poland , Philippines , Peru , Kuwait , South Korea , Japan , Italy , India , Israel , United Arab Emirates , Greece , United Kingdom , France , Spain , Egypt , Algeria , Denmark , Czechia , China , Chile , Switzerland , Belarus , Azerbaijan , Austria
- Last Updated
- 3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.